SCHEMBL5659475

SCHEMBL5659475

COc1cc(C=O)c2cc(Cc3ccccc3)oc2c1OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
KDM4E B2RXH2 3/20 0.48
HTT P42858 2/20 0.48
POLB P06746 1/20 0.48
GAA P10253 1/20 0.48
GPR55 Q9Y2T6 4/20 0.44
CNR2 P34972 4/20 0.44
HPGD P15428 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MCL1 Q07820 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA13 Q8N1Q1 1/20 0.41
CNR1 P21554 2/20 0.40
TUBB1 Q9H4B7 1/20 0.39
MAOA P21397 1/20 0.38
DRD2 P14416 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5657738 0.93 ALDH1A1 (0.42) ALDH1A1KDM4EHTTPOLBGAA
SCHEMBL5657441 0.89 TUBB1 (0.43) ALDH1A1KDM4EHTTPOLBGAA
SCHEMBL5660910 0.88 GPR55 (0.46) ALDH1A1KDM4EHTTPOLBGAA
SCHEMBL5722780 0.85 GPR55 (0.43) ALDH1A1KDM4EHTTPOLBGAA
SCHEMBL5657720 0.81 KDM4E (0.46) ALDH1A1KDM4EHTTPOLBGAA
SCHEMBL5656669 0.80 KDM4E (0.46) ALDH1A1KDM4EHTTPOLBGAA
SCHEMBL5660061 0.80 ACHE (0.54) ALDH1A1KDM4EGAAHPGDMCL1
SCHEMBL5656339 0.80 LMNA (0.43) ALDH1A1KDM4EHTTPOLBGAA
SCHEMBL5660258 0.78 TUBB1 (0.43) ALDH1A1CNR2HPGDSMN1; SMN2CA12
SCHEMBL5657689 0.78 CA12 (0.38) ALDH1A1KDM4EGAAHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030130-B2 Benzofuran derivatives and their use as antibacterial agents ARPIDA AG (CH) 2006-04-18 US disclosed
EP-1307445-B1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ARPIDA AG (CH) 2005-12-21 EP disclosed
US-20040034047-A1 Benzofuran derivatives and their use as antibacterial agents EVOLVA SA (CH) 2004-02-19 US disclosed
EP-1307445-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS Arpida AG, (CH) 2003-05-07 EP disclosed
WO-2002010157-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ARPIDA AG (CH) 2002-02-07 WO disclosed
WO-2002010156-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ARPIDA AG (CH) 2002-02-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034047-A1 Benzofuran derivatives and their use as antibacterial agents SBDS, BPTF, DCXR ALDH1A1 1365/4885KDM4E 1540/4885HTT 3152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.